Extrahepatic manifestations of cholestatic liver diseases: pathogenesis and therapy
- PMID: 15879620
- DOI: 10.1385/CRIAI:28:2:147
Extrahepatic manifestations of cholestatic liver diseases: pathogenesis and therapy
Abstract
Pruritus, fatigue, and metabolic bone disease are frequent complications of cholestatic liver diseases, which can be quite distressing for the patient and can considerably reduce the quality of life. The molecular pathogenesis of these extrahepatic manifestations of cholestasis is poorly understood, and hypotheses to explain these symptoms are being discussed. This article provides treatment recommendations for the complications of cholestasis based on putative pathomechanisms and summarizes recent experimental and clinical data involving management options.
Similar articles
-
[Progress in diagnosis and therapy of extrahepatic manifestations of cholestatic liver diseases].Zhonghua Gan Zang Bing Za Zhi. 2016 Aug 20;24(8):561-564. doi: 10.3760/cma.j.issn.1007-3418.2016.08.001. Zhonghua Gan Zang Bing Za Zhi. 2016. PMID: 27788700 Chinese.
-
Care of the cholestatic patient.Clin Liver Dis. 2013 May;17(2):331-44. doi: 10.1016/j.cld.2012.11.005. Epub 2012 Dec 20. Clin Liver Dis. 2013. PMID: 23540506 Review.
-
Pathogenesis and Management of Pruritus in PBC and PSC.Dig Dis. 2015;33 Suppl 2:164-75. doi: 10.1159/000440829. Epub 2015 Dec 7. Dig Dis. 2015. PMID: 26641452 Review.
-
Extrahepatic manifestations of cholestasis.J Gastroenterol Hepatol. 2002 Sep;17(9):938-48. doi: 10.1046/j.1440-1746.2002.02717.x. J Gastroenterol Hepatol. 2002. PMID: 12167113 Review.
-
Use of oral naltrexone for severe pruritus due to cholestatic liver disease in children.J Pediatr Gastroenterol Nutr. 2010 Dec;51(6):787-9. doi: 10.1097/MPG.0b013e3181eb5ac0. J Pediatr Gastroenterol Nutr. 2010. PMID: 20948447 No abstract available.
Cited by
-
Modeling hepatic osteodystrophy in Abcb4 deficient mice.Bone. 2013 Aug;55(2):501-11. doi: 10.1016/j.bone.2013.03.012. Epub 2013 Mar 29. Bone. 2013. PMID: 23545228 Free PMC article.
-
Use and indications of cholestyramine and bile acid sequestrants.Intern Emerg Med. 2013 Apr;8(3):205-10. doi: 10.1007/s11739-011-0653-0. Epub 2011 Jul 8. Intern Emerg Med. 2013. PMID: 21739227 Review.
-
Low bone mineral density and the severity of cholestasis in biliary atresia.World J Hepatol. 2017 Jun 8;9(16):746-751. doi: 10.4254/wjh.v9.i16.746. World J Hepatol. 2017. PMID: 28652893 Free PMC article.
-
Pathogenesis and treatment of pruritus in cholestasis.Drugs. 2008;68(15):2163-82. doi: 10.2165/00003495-200868150-00006. Drugs. 2008. PMID: 18840005 Review.
-
Cholestasis and metabolic bone disease - a clinical review.Wien Med Wochenschr. 2008;158(19-20):553-7. doi: 10.1007/s10354-008-0594-z. Wien Med Wochenschr. 2008. PMID: 18998071 Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical